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Abstract
Background: Transforming growth factor β proteins (Tgfβs) are secreted cytokines with well-defined functions in the 
differentiation of the musculoskeletal system of the developing limb. Here we have studied in chicken embryos, 
whether these cytokines are implicated in the development of the embryonic limb bud at stages preceding tissue 
differentiation.
Results: Immunohistochemical detection of phosphorylated Smad2 and Smad3 indicates that signaling by this 
pathway is active in the undifferentiated mesoderm and AER. Gene expression analysis shows that transcripts of tgfβ2 
and tgfβ3 but not tgfβ1 are abundant in the growing undifferentiated limb mesoderm. Transcripts of tgfβ2 are also 
found in the AER, which is the signaling center responsible for limb outgrowth. Furthermore, we show that Latent Tgfβ 
Binding protein 1 (LTBP1), which is a key extracellular modulator of Tgfβ ligand bioavailability, is coexpressed with Tgfβs 
in the early limb bud. Administration of exogenous Tgfβs to limb buds growing in explant cultures provides evidence 
of these cytokines playing a role in the regulation of mesodermal limb proliferation. In addition, analysis of gene 
regulation in these experiments revealed that Tgfβ signaling has no effect on the expression of master genes of 
musculoskeletal tissue differentiation but negatively regulates the expression of the BMP-antagonist Gremlin.
Conclusion: We propose the occurrence of an interplay between Tgfβ and BMP signaling functionally associated with 
the regulation of early limb outgrowth by modulating limb mesenchymal cell proliferation.
Background
Tgfβs constitute a subfamily formed in birds and mam-
mals by 3 isoforms of secreted cytokines (T gfβ1; T gfβ2;
Tgfβ3), which gives the name to the large Tgfβ superfam-
ily made up of more than 30 structurally related proteins
that comprises Activins, BMPs and GDFs. Tgfβs are mul-
tifunctional factors with important regulatory roles in
adult and embryonic systems. During development Tgfβs
are able to regulate almost all basic cellular processes
including migration, proliferation, apoptosis and differ-
entiation (reviewed by [1]). Their effects are mediated by
binding to specific cell surface transmembrane receptors
with serine/threonine kinase activity that trigger an intra-
cellular cascade which regulates the expression of target
genes and the biogenesis of specific microRNAs
(reviewed by [2]). This basic signaling pathway is finely
modulated by a large number of cofactors acting both at
extracellular or intracellular levels which results in a vari-
ety of different responses depending on the lineage or the
context of the target cells (reviewed by [3,4]). As a rele-
vant example of this regulation, Tgfβs are secreted as
latent precursor molecules covalently bound to latent
Tgfβ-binding proteins (LTBP), which are components of
the extracellular matrix. LTBPs act as a store for the
cytokine but are also required for its activation [5].
Modulation of Tgfβs activity is also finely tuned at
intracellular level. In the canonical signaling pathway, the
activation of receptors results in phosporilation of Smad
* Correspondence: hurlej@unican.es
1 Departamento de Anatomía y Biología Celular. Universidad de Cantabria/
IFIMAV. Santander 39011. Spain
† Contributed equally
Full list of author information is available at the end of the articleLorda-Diez et al. BMC Developmental Biology 2010, 10:69
http://www.biomedcentral.com/1471-213X/10/69
Page 2 of 10
2 and Smad 3 proteins which, upon binding with the
adaptor Smad 4, translocate to the nucleus functioning as
transcriptional regulators [3]. However, there are alterna-
tive and/or complementary intracellular pathways, like
MAP kinases, activated in a cell-context dependent fash-
ion. Furthermore, many intracellular regulators modify
the pattern of gene activation/inhibition evoked by phos-
phorylated Smad proteins [6]. Hence, an appropriate
functional characterization of these cytokines in the dif-
ferent systems will be improved by the identification of
cofactors associated with the signaling pathway.
During limb development Tgfβs has been characterized
as important regulators of the differentiation of the mus-
culoskeletal system including cartilage, joint and tendon
differentiation and morphogenesis [7-12] and myogenesis
[13,14]. Possible roles in angiogenesis [15] and pro-
grammed cell death [16] have also been proposed. How-
ever, since the phenotype in mice with targeted
alterations of this signaling pathway reflects large altera-
tions of tissue differentiation and organogenesis of the
musculoskeletal system [9-11], the possible implications
of these cytokines during the initial stages of limb devel-
opment have been largely neglected. Here we show that
prior to the stages of tissue differentiation, Tgfβ2  and
Tgfβ3 are coexpressed with Ltbp1 in the undifferentiated
mesoderm and in the AER of the early limb bud. In addi-
tion, we provide evidence of a function of these factors in
the regulation of mesodermal limb proliferation and in
the modulation of the activity of Gremlin, a gene that is
involved in the control of BMP signaling, a pathway of
major importance in limb outgrowth and patterning.
Results
Phospho-Smad immunolabeling
To explore the spatial distribution of Tgfβ-signaling, we
examined the distribution of phospho-Smad 2 (p-Smad 2)
and phospho-Smad 3 (p-Smad 3) by immunolabeling in
embryonic limb tissue sections. As shown in Fig 1 nuclear
labeling for both phospho-smads was intense in the AER
and in the undifferentiated cells subjacent to the ecto-
derm and almost negative in the central chondrogenic
region of the limb bud. Positive labeling of the undifferen-
tiated mesoderm was highest in the distal mesoderm
underlying the AER and more reduced at proximal levels
of the bud, in the mesoderm located under the dorsal and
ventral ectoderm. Importantly, the undifferentiated
mesoderm underlying the AER, which is termed the
"progress zone mesoderm" is responsible for outgrowth
of limb along the proximo-distal axis.
Expression of Tgfβs is coincident with regions of Smad 2, 
and Smad 3 activation
Initial studies of Tgfβ gene expression by Q-PCR showed
that Tgfβ2 and Tgfβ3 are the main components of this
family expressed in the early developing limb and the
number of transcripts increases as development proceeds
(Figure 2A). In contrast Tgfβ1 (formerly Tgfβ4 in chicken)
is expressed at very low levels. Expression levels of
Activins and Nodal were also analyzed because these fac-
tors also activate Smad 2 and Smad 3 signaling. However,
transcripts of Activin beta A and B subunits were almost
undetectable (Figure 2B) and Nodal  was absent (not
shown). The pattern and intensity of gene expression of
Tgfβ  genes obtained by QPCR was similar in the early
wing and leg buds (not shown), but domains of expres-
sion were better detected by in situ hybridization in the
former.
Transcripts of Tgfβ2  are first detected in the somatic
mesoderm associated with the limb region at stage
HH17-18 (Figure 3A). Next in development (stages
HH19-22), transcripts are widespread through the limb
mesoderm with domains of increased expression in the
posterior and ventral regions of the bud (Figure 3B-E). By
stages HH23 and HH24 expression is concentrated in the
dorsal and ventral regions of the limb bud (Figure 3F-G).
At these stages a mild but significant labeling is also
observed in the AER (Figure 3H). From stage HH26
onwards labeling is associated with the developing digits
and its expression pattern has been previously reported
[12,17]. Tgfβ3 is expressed in the undifferentiated meso-
derm of the early limb bud without specific domains until
stage HH24, when transcripts accumulated in the dorsal
and ventral mesoderm in the region occupied by the pre-
muscular masses (Figure 3I).
Tgfβ1 expression by in situ hybridization is almost
absent from the limb bud and lacks specific domains of
expression.
Expression and regulation of LTBP genes
To better characterize the signaling pathway activated by
Tgfβs in the early limb bud we decided to study the
expression of LTBPs as potential players of active Tgfβ
delivery (Figure 4). In vertebrates there are 3 LTBP iso-
forms, namely LTBP-1, -3 and -4, which are able to bind
and deliver Tgfβs [18] while the function of LTBP-2
remains uncertain [19]. We have studied by in situ
hybridization the pattern of expression in the developing
chicken limb of Ltbp1, 2 and 3 and all of them showed
specific expression domains.
In the early limb bud, Ltbp1 is highly expressed in the
AER (Figure 4A-B) and with much reduced intensity in
the non-ridge ectoderm. By stage HH24 transcripts were
also abundant in the dorsal mesoderm (F igure 4C). A t
later stages, expression of Ltbp1 was very intense in the
condensing prechondrogenic aggregates of the develop-
ing digits (Figure 4F) where Tgfβs exert an important role
in tissue differentiation [12]. Analysis of local gene regu-
lation following local application of beads bearing BMP7,Lorda-Diez et al. BMC Developmental Biology 2010, 10:69
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another well characterized regulator of limb develop-
ment, showed an intense negative influence of BMPs on
Ltbp gene expression in the AER (Figure 4D). This nega-
tive expression regulation was more intense than that
induced in the markers of the AER, like Fgf8 (Figure 4E).
Prior to stage HH25, Ltbp2 was coexpressed with Ltbp1
in the AER (Figure 4G). At more advanced stages of
development, Ltbp2 was expressed in the developing dig-
its marking the zones of joint formation (Figure 4H-I).
Ltbp3 was not detected by in situ hybridization in the
early limb bud. At more advanced stages Ltbp3  was
expressed at very low levels in the differentiating phalan-
geal perichondrium and interphalangeal joints (not
shown).
In view of the spatial distribution of the Ltbp1 tran-
scripts described above, we next analyzed by immunohis-
tochemical approaches whether its protein distribution
corresponded with regions of high Smad signaling. As
shown in Figure 5 at initial stages of limb development,
LTBP1 immunolabeling showed positive labeling in the
ectodermal cells, with higher intensity in the AER (Figure
5A-A''). In addition a dotted labeling pattern was also
appreciated in the mesodermal extracellular matrix (Fig-
ure 4B-B''), which correlated with the zones of intense p-
Smad2 and 3 immunolabeling (see Figure 1). Neither the
cellular nor the extracellular labeling was present in con-
trol sections unexposed to the primary antibody (Figure
5C-C'').
Figure 1 pSmad 2 and 3 distribution during early limb development. (A) Immunolabeling for p-Smad2 in limb buds at stage HH24 showing neg-
ative labeling of the central chondrogenic mesenchyme (c) in contrast with the subectodermal mesoderm and the intense positivity of the AER. (B) 
Detailed view of the distal tip of the limb bud at stage HH24 showing positive nuclear p-smad 3 immunolabeling (green) in the AER and distal mes-
enchyme contrasted with cytoplasmic phalloidin-TRITC labeling (red). B' shows only the green channel in B to see the positive nuclear labeling. (C) 
Detailed view of pSMAD3 nuclear labeling (green) counterstained with phalloidin (red). C' shows only green channel in C.
Figure 2 Expression levels of different members of transforming growth factor β subfamily in the limb bud. (A-B) Charts in A and B show the 
relative level of expression for the members of the Tgfβ subfamily (A) and for Activin subunits βa and βb (B). Note that tgfβ1 gene expression is the 
lowest of the three members of the family either at early limb bud stages (HH20; bars on the left in A) or at intermediate stages of limb development 
(HH24; bars on the right in A). (B) Activin βa and Activin βb displayed almost undetectable levels of expression by QPCR at the same stages of limb 
development. Nodal expression was totally absent and is not shown on the chart. All data was analyzed by real time QPCR and tgfβ1 expression at 
HH20 was used as calibrator. (*) p-value ≤ 0,05 or (**) p-value ≤ 0.01 or (***) p-value ≤ 0.001 using HH20 tgfβ1 expression level as calibrator.Lorda-Diez et al. BMC Developmental Biology 2010, 10:69
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Exogenous Tgfβs inhibit proliferation in limb bud explants
T aking into account that T gfβ signaling is active in the
AER and progress zone mesenchyme prior to the onset of
tissue differentiation we decided to explore the possible
influence Tgfβ-signaling in the control of mesodermal
cell proliferation. To check this potential function we set
u p  c u l t u r e s  o f  t h e  w h o l e  l e g  b u d s  a t  s t a g e s  H H 2 0  o r
HH21 and mesodermal cell proliferation was evaluated
by flow cytometry in untreated control explants and in
explants cultured for 18 hr in presence of 0.033 μg/ml
TGFβ1. As shown in Fig 6, cell proliferation in the treated
explants was seen to undergo a 35% reduction in compar-
ison with untreated cultures.
Tgfβs regulate Gremlin gene expression in the early 
growing limb bud
In view of the reduced proliferation observed in limb
explants cultured in presence of Tgfβ we explored by
QPCR changes in the expression of genes implicated in
the control of limb outgrowth. In previous experiments
Figure 3 Tgfβ gene expression in the developing limb. (A-H) Gene 
expression of tgfβ2 analyzed by in situ hybridization. (A) Whole mount 
in situ hybridization of an embryo at stage HH18 showing transcripts 
of tgfβ2 at the level of the limb field in the somatic mesoderm on the 
flank of the embryos (arrow). (B) Transverse vibratome section at the 
level of the wing bud (W) of an embryo at stage HH19 showing intense 
labeling in the somatopleura and associated limb mesenchyme (black 
arrow). Note also tgfβ2 transcripts in the floor plate of the neural tube 
(NT) and notochord (white arrow). (C-E) Detailed views of the wing bud 
at stages HH20 (C), HH21 (D), and HH22 (E) showing the expression do-
main of tgfβ2 in the mesenchyme of the posterior margin of the bud 
(arrows). (F-H) Tgfβ2 expression domains at stage HH24 are present in 
the dorsal and ventral mesoderm and in the AER. (F) Longitudinal vi-
bratome section of the wing bud showing the intense accumulation 
of transcripts in the dorsal and ventral mesoderm associated with the 
premuscle masses, and a more reduced expression in the distal un-
diferentiated mesoderm (arrows). (G and H) are whole mount speci-
mens illustrating the dorsal expression domain (G) and the AER 
domain (H). (I) Longitudinal section of the embryonic wing bud at 
stage HH24 showing the expression of tgfβ3 in the dorsal and ventral 
regions outlining the territory that is occupied by the premuscle mass-
es. Note lower levels of expression in the undifferentiated distal limb 
mesoderm (arrow).
Figure 4 Expression of Ltbps in the developing limb. (A-F) Expres-
sion and regulation of Ltbp-1. (A) Whole mount in situ hybridization of 
Ltbp-1 gene showing intense labeling in the apical ectodermal ridge of 
the developing leg bud at stage HH20. (B-C) Whole-mount in situ hy-
bridizations showing the expression of Ltbp-1 at stage HH24. Note that 
in addition to the AER domain, expression is also observed in the dorsal 
surface of the limb bud (arrows). (D) Image shows a dramatic down-
regulation of Ltbp1 in the AER eight hours after the application of a 
BMP7- bead in the progress zone mesoderm (arrow). Compare the ab-
sence of labeling in the treated left limb with respect to the contralat-
eral untreated control. (E) Whole mount in situ hybridization showing 
a more moderate downregulation of Fgf8 in the AER in a limb bud sub-
jected to the same treatment to that shown in D (arrow shows the po-
sition of the BMP-bead). (F) Whole mount in situ hybridization showing 
the expression of Ltbp1 in the developing digits at stage HH26. (G-I) Ex-
pression of Ltbp2 in early (stage HH20; G) and late stages of limb devel-
opment (stages HH30 and HH32; H and I). Note the expression domain 
in the AER of early limb buds (arrow in G) and the domains of the de-
veloping interphalangeal joints at the stages of digit morphogenesis 
(arrowheads in H and I).Lorda-Diez et al. BMC Developmental Biology 2010, 10:69
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we observed that neither Scleraxis nor Sox 9 or MyoD
were regulated after 18 hr of culture in presence of TGFβs
(Figure 7A), thus ruling out these cytokines having an
effect inducing a precocious differentiation of the limb
mesenchyme (see below). As markers for factors involved
in the control of limb outgrowth we chose Fgf8, Fgf10 and
the BMP antagonist Gremlin. Neither Fgf8  nor  Fgf10
expression were significantly modified in the 18 hr time-
period of culture chosen for these experiments, although
the levels of expression of Fgf10 were always lower in the
treated limbs (Figure 7A). In contrast, during the same
time period Gremlin was intensely down-regulated (Fig-
ure 7A). This in vitro regulation of gene expression was
also confirmed in vivo by in situ hybridization following
the implantation of beads bearing TGFβ1 or TGFβ2 into
the limb primordium (4 out of 5 experiments; Figure 7B).
Since Gremlin, by neutralizing BMPs, contributes
towards maintaining the expression of Fgf8 in the AER
[20], we next explored, by in situ hybridization, changes
in the expression of Fgf8 in explants, or in the limb buds
in vivo, exposed to TGFβ1 for longer time periods. Differ-
ences were not appreciated in explants during the first 24
hr of culture (Fig 7C-D) but a moderate downregulation
of Fgf8 in the AER was appreciated in limbs 30 hr after
the implantation of heparin beads bearing TGFβ1 (2 out
of 5 experimental embryos; Figure 7E-F)
Figure 5 LTBP1 immunolabeling in the early limb bud. (A-B'') LTBP1 immunolabeling (green) counterstained with cytoplasmic phalloidin-TRITC 
labeling (red) of an early limb bud section (stage HH22) at the level of the AER. In all cases the merge images (A and B); the green channel for LTBP1 
immunolabeling (A' and B'); and the red channel for actin labeling with phalloidin-TRITC (A'' and B'') are shown. (A-A") Note the strong labeling of the 
cells of the AER and the positive extracellular dotted labeling pattern in the underlying mesenchyme. (B-B'') detailed view of the region outlined by 
an square in A', showing the positive labeling of the matrix. Note the absence of overlapping between the cytoplasmic red labeling and the green 
spots indicative of its location in the pericellular space. (C-C'') Control section of a similar sample unexposed to the primary antibody for LTBP1.Lorda-Diez et al. BMC Developmental Biology 2010, 10:69
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Figure 6 Effect of Tgfβ treatments on mesodermal proliferation in early limb buds. (A) Representative flow cytometry histograms to evaluate 
proliferation in limb bud explants of stage HH20/21 cultured for 18 hours in control media or in a medium supplemented with 0.033 μg/ml Tgfβ1 after 
labeling with Edu. (Left): control unlabeled sample; (middle): control sample untreated with Tgfβ; (right) Tgfβ treated sample. The percentage of la-
beled cells is indicated in the histogram. (B) Bars graph summarizing the rate of cell proliferation in control and treated limb explants.Lorda-Diez et al. BMC Developmental Biology 2010, 10:69
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Discussion
Our study provides evidence of the implication of Tgfβ
signaling in early stages of limb development. The distri-
bution of phosphorylated Smad 2 and 3 in the limb bud
indicates that the AER, the distal undifferentiated meso-
derm, and the dorsal and ventral mesoderm are zones of
remarkable signaling activity, while the differentiating
central core mesoderm at these stages is almost negative.
According to our expression analysis Tgfβ2 and Tgfβ3 are
the two members of this family accounting at these stages
for active signaling in the developing limb, while Tgfβ1
and other members of the Tgfβ superfamily signaling
through Smad 2/3 (Activins and Nodal) are almost
absent. We have also observed that the zones of active
signaling correlated closely with the domains of expres-
sion of Ltbp1, which is an important extracellular regula-
tor of the signaling pathway. In physiological conditions,
Tgfβs are secreted as inactive complexes consisting of
Tgfβ cytokine, a N-terminal latency associated peptide
(LAP) and Latent Tgfβ binding protein (LTBP; [5]). Stud-
ies in a variety of systems have shown that LTBP regulates
the bioavailability of Tgfβs facilitating its secretion, stor-
ing the inactive Tgfβ within the extracellular matrix, and,
regulating its activation in the pericellular space (see
[21,22]). Accordingly, Tgfβ activity appears decreased in
mice harboring mutations of Ltbp genes (see [23]). Con-
sistent with these functions we have observed that
domains of expression of Ltbp1 correlate closely with the
zones of high p-Smad 2 and 3 immunolabeling.
A considerable number of studies have previously
addressed the role of Tgfβs in limb development. From
these studies Tgfβ signaling is currently associated with
regulation of chondrogenesis, tenogenesis, myogenesis
and joint formation [9-14]. Here we observed that meso-
dermal proliferation is significantly reduced in limb bud
explants cultured in presence of Tgfβs. These findings are
consistent with the recognized antiproliferative effects of
Tgfβ in other systems [24], but the precise mechanism
responsible for such reduced mesodermal cell prolifera-
tion following treatments with Tgfβs remains elusive. The
absence of up-regulation in the expression of Scleraxis,
Sox 9 and MyoD, which are major regulators of tendon,
cartilage and muscle differentiation respectively, contrast
with the intense regulation of these factors observed at
more advanced stages of limb development [11,12,25].
This finding rules out the posibility that inhibition of pro-
liferation was secondary to the initiation of mesodermal
cell differentiation and reveals a different stage-depen-
d e n t  r e s p o n s e  o f  t h e  l i m b  m e s o d e r m  t o  t h i s  s i g n a l i n g
pathway. We have also observed that expression of Fgf8
and Fgf10, which are key factors in the control of limb
Figure 7 Gremlin expression is modulated by Tgfβ signaling in 
the early limb bud. (A) Charts shows QPCR results for different genes 
from limb explants of stage HH20/21 cultured for 18 hours in control 
media (grey bars) or supplemented with 0.033 μg/ml Tgfβ1 (white 
bars). From left to right we show results for gremlin, fgf8, fgf10, scleraxis, 
sox9 and myoD. Each pair of bars shows control sample on the left and 
experimental situation on the right. The level of expression in controls 
was used as calibrator for each gene. Only Gremlin expression shows 
significantly lower levels of expression after Tgfβ treatments. (*) p-val-
ue ≤ 0,05 using control expression level as calibrator. (B) In situ hybrid-
ization showing down-regulation of Gremlin 8 hr after the implantation 
of a Tgfβ1-loaded bead (*) in the right wing bud. (C-D) expression of 
Fgf8 in control (C) and Tgfβ treated limb explant (D) after 20 hr of cul-
ture. Note that expression is similar in control and experimental ex-
plants. (E-F) expression of Fgf8 in the AER of control (E) and 
experimental limb bud (F) 30 hr after the implantation of a Tgfβ-bead 
in the mesoderm subjacent to the AER (arrow). Note the irregularity of 
the expression domain in the experimental limb in comparison with 
the control untreated limb.Lorda-Diez et al. BMC Developmental Biology 2010, 10:69
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outgrowth [26,27], is not modified in short term treat-
ments with Tgfβs. Consistent with our findings, up-regu-
lation of Tgfβ signaling has been previously proposed as
being responsible for reduced limb outgrowth in different
experimental approaches [28,29], however, mutants with
defective Tgfβ signaling tend to exhibit limbs of reduced
rather than elongated size [10]. In the case of Tgfβ2-defi-
cient mice, which is the predominant member of the fam-
i l y  e x p r e s s e d  a t  e a r l y  s t a g e s  o f  l i m b  d e v e l o p m e n t ,  t h e
limbs appear grossly deformed and abnormally rotated
accompanied by a reduced size of the zeugopodial skele-
ton of the forelimb [30]. Hence, the effect on cell prolifer-
a t i o n  d e t e c t e d  i n  o u r  s t u d y  d o e s  n o t  a p p e a r  t o  b e
reflected in the phenotype of mice with defective Tgfβ-
signaling. It is likely that this influence in proliferation
might be obscured in the course of development as Tgfβs
at more advanced stages of development are abundantly
expressed in the growth plate of long bones and partici-
pate in the control of chondrocyte differentiation, prolif-
eration, matrix synthesis, and mineralization [31].
Studies on a variety of developing systems have pro-
vided evidence of a functional interplay between Tgfβ-
and BMP-signaling. A good example of these interactions
is observed in the growth plate of postnatal mice. In this
system chondrocyte maturation involves a coordination
between negative and positive effects of Tgfβs and BMPs
respectively [31]. In the developing limb the formation of
the cartilaginous primordia of the digits appears to also
be regulated by the local interplay between both signaling
pathways [32]. Here we have shown that Tgfβ-signaling
has a negative influence in the expression of Gremlin, a
secreted BMP antagonist that has a key function in the
maintenance of limb outgrowth [20,33,34]. The physio-
logical function of Gremlin is to counteract the negative
effects of BMPs on the AER [35,36] and its downregula-
tion at the end of limb morphogenesis causes the termi-
nation of limb outgrowth [37]. Altogether these findings
suggest the occurrence of a negative interactive loop
between Tgfβs and BMPs implicated in the regulation of
limb outgrowth. However, additional and/or alternative
growth regulatory mechanisms cannot be ruled out, as
the decreased mesodermal limb proliferation caused by
Tgfβ treatments was detected prior to the down-regula-
tion of Fgf8 in the AER. Another possibility, which cannot
be ruled out, is that the interaction between Tgfβs and
BMPs was also associated with the recent demonstrated
function of Tgfβs modulating the response of early limb
mesodermal cells to BMP-signaling (see [38]).
Conclusions
The possible role of Tgfβs in early limb bud development
has been poorly studied to date. Here we have character-
ized the expression of the different Tgfβs  and the Tgfβ
extracellular regulators Ltbps in this model. The expres-
sion in the Apical Ectodermal ridge and undifferentiated
mesoderm, together with the pattern of activation of the
intracellular Tgfβ canonical pathway mediated by Smads
transcription factors, indicate a possible role of these
cytokines modulating limb bud outgrowth. Indeed we
further show that Tgfβs reduce cell proliferation in the
undifferentiated limb mesenchyme. Concomitant with
this role we find that BMP and TGFβ signaling pathways
establish a cross-regulation of their modulators Ltbp1
and Gremlin respectively during early limb bud develop-
ment.
Methods
In this work, we employed Rhode Island chicken embryos
ranging from 2,5 to 5 days of incubation corresponding to
stages 18 to 32 of Hamburger and Hamilton (HH).
In vivo experimental manipulation of the limb
Eggs were windowed at the desired stages and experi-
mental manipulations of the limb were performed in the
right leg bud using forceps to handle the embryo and
membranes. Local treatments were performed by appli-
cation at the desired regions of heparin (Sigma) or Affi-
Gel blue (BioRad) beads incubated for 1 hour in 5 μg/ml
Tgfβ1, 5 μg/ml Tgfβ2, (R&D Systems) or 0,5 mg/ml BMP7
(a gift of Creative Biomolecules, Hopkinton, MA). After
manipulation, the eggs were sealed and changes in gene
expression were analyzed by in situ hybridization
Explant cultures
Limbs of stages HH20 or HH21 embryos were sectioned
using iridotome and placed on 0.4 μm Culture Plate
Insert Millicell (Millipore) for further culture in DMEM
(100 units/ml penicillin and 100 μg/ml streptomycin). In
experimental explants 0.033 μg/ml Tgfβ1 were added to
the medium. After 18-20 hr of culture samples were pro-
cessed for mRNA extraction and QPCR analysis.
Flow cytometry
Limb explants of stage HH20/21 cultured for 18 hours in
control media or in a medium supplemented with 0.033
μg/ml Tgfβ1 were dissociated to single-cell level in order
to perform flow cytometry analysis based on direct DNA
labeling of proliferating mesodermal cells using 5-ethy-
nyl-2'-deoxyuridine (EdU) chemistry [39]. The EdU label-
ing was performed using the Click-iT EdU Alexa Fluor
488 Flow Cytometry Assay Kit (Invitrogen) according to
the manufacturer's instructions. Each sample consisted of
8 limb buds.
Antibodies, immunolabeling and Confocal Microscopy
The following primary polyclonal rabbit antibodies were
used: phospho-Smad2 (Ser465/467; Cell Signaling); phos-
pho-Smad3 (Cell Signaling); and LTBP1 (Santa Cruz sig-
naling). Actin staining using 1% or Phalloidin-TRITCLorda-Diez et al. BMC Developmental Biology 2010, 10:69
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(Sigma) was performed to mark cytoplasm and enhance
nuclear or extracellular labeling. For immunolabeling
samples were fixed in 4% paraformaldehyde and sec-
tioned 100 μm thick in a vibratome. Samples were exam-
ined with a laser confocal microscope (LEICA LSM 510)
by using a Plan-Neofluar 10×, 20× or Plan-Apochromat
63× objectives, and an argon ion laser (488 nm) to excite
FITC fluorescence and a HeNe laser (543 nm) to excite
TRITC.
Probes and in situ hybridization
In this study we used probes for tgfβ2 [8], tgfβ3 [8], grem-
lin [40], fgf8 and fgf10, (kindly provided by Cliff Tabin). In
addition, fragments of chicken tgfβ1,  ltbp1,  ltbp2  and
ltbp3  genes were obtained by RT-PCR. First-strand
cDNA was synthesized with random hexamers and M-
MulV reverse transcriptase (Fermentas) and 1 mg of total
RNA from day 7 autopods. The following primers were
used for subsequent PCR amplification: for tgfβ1 5'-tct-
tcgtgttcaacgtgtcc-3' and 5'-cgcagcagttcttctcatcc-3'; for
ltbp-1  5'-tgcatcaaacctaactgtgca-3' and 5'-tcggaagttagtg-
gctgtca-3'; for ltbp-2  5'-agatccacctggatgtctgc-3' and 5'-
ctcacagccattgagaatgc-3' and for ltbp-3 5'-attcggaggagca-
gagc and 5'-tggcagtggcagttgtagg -3'.
The PCR conditions were 94°C, 4 min and then 35
cycles of 94°C, 20 s; 60°C, 30 s; 72°C, 60 s; and final exten-
sion at 72°C, 10 min. PCR products were subcloned into
pGEM T-easy (Promega). Sequencing of the probes was
performed to verify specificity. Digoxygenin-labeled
sense and antisense RNA probes were generated for in
situ hybridization analysis.
In situ hybridization of control and treated limbs was
performed in 100 μm vibratome sectioned specimens.
Samples were treated with 10 μg/ml of proteinase K for
20-30 minutes at 20°C. Hybridization with fluorescein or
digoxigenin labeled antisense RNA probes was per-
formed at 68°C. Alkaline phosphatase-conjugated anti-
digoxigenin antibody (dilution 1:2000) was used (Roche).
Reactions were developed with BCIP/NBT substrate as
the chromogene (Roche).
Real time quantitative PCR (Q-PCR) for gene expression 
analysis
In each experiment total RNA was extracted and cleaned
from specimens using the RNeasy Mini Kit (Qiagen).
RNA samples were quantified using a spectrophotometer
(Nanodrop Technologies ND-1000). First-strand cDNA
was synthesized by RT-PCR using random hexamers, the
M-MulV reverse transcriptase (Fermentas). The cDNA
concentration was measured in a spectrophotometer
(Nanodrop Technologies ND-1000) and adjusted to 0.5
μg/μl. Q-PCR was performed using the Mx3000P system
(Stratagene) with automation attachment. In this work,
we have used SYBRGreen based QPCR. Gapdh had no
significant variation in expression across the sample set
and therefore was chosen as the normalizer in our experi-
ments. Mean values for fold changes were calculated for
each gene. Expression level was calculated relative to a
calibrator according to the 2-(ΔΔCt) equation [41]. Each
value in this work represents the mean values and SEM of
at least three independent samples obtained under the
same conditions. Each sample consisted of 4 limb buds.
Data were analyzed using one-way ANOVA followed by
Bonferroni tests for post-hoc comparisons between
expression levels of Tgfβs, and Student-t-test for gene
expression levels in the treated developing limbs. Statisti-
cal significance was set at p < 0.05. All the analyses were
done using SPSS for Windows version 15.0. Primers for
QPCR were: for sox9 5'-gaggaagtcggtgaagaacg -3' and 5'-
gatgctggaggatgactgc -3'; for scleraxis 5'-caccaacagcgtcaa-
cacc -3' and 5'-cgtctcgatcttggacagc -3'; for fgf8 5'-cgtgt-
tcatgcacttgttcg -3' and 5'-gatctgtcaccaggctctgc -3'; for
fgf10 5'-atcgagaagaacggcaagg -3' 5'-ggacttaactgccacaactcc
-3'; for tgfβ1 5'-acctcgacaccgactactgc -3'and 5'-cttccactg-
cagatccttgc -3'; for tgfβ2 5'-tgcactgctatctcctgagc -3' and
5'-gcatgaactgatccatgtcg -3'; for tgfβ3 5'-ctcagtggcaggaat-
gtgc -3'and 5'-cgaggttggactctctgtgc-3'; and for gremlin 5'-
agtcgcaccattatcaacagg -3'and 5'-ttgcagaaggaacaagactgg -
3'; for nodal  5'-ccaagaagtacaacgcctacc -3'and 5'-gcatg-
tacgcgtgattgc -3'; for activin βA 5'-gctgactgtccatcatgtgc -
3'and 5'-actgcttccaccatctcagg -3'; for activin βB 5'-tggat-
catagcaccatcagg -3'and 5'-gcattcggtacttgattcacg -3'; myoD
5'-acggcatgatggagtacagc -3'and 5'-tccgtgtagtagctgctgtcg -
3'.
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